MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$1,290,978
Prepaid expenses and
other assets
$84,975
Total current assets
$1,375,953
Operating lease
right-of-use assets
$57,410
Total assets
$1,433,363
Accumulated deficit
-$56,106,019
Total liabilities and
stockholders deficit
$1,433,363
Total stockholders
deficit
-$1,978,337
Additional paid-in capital
$54,110,425
Common stock, 0.0001
par value...
$17,257
Total liabilities
$3,411,700
Deferred revenue
$3,000,000
Total current
liabilities
$382,320
Operating lease
obligations, less current...
$29,380
Accounts payable
$319,803
Accrued expenses and
other liabilities
$33,536
Current portion of
operating lease...
$28,981
Back
Back
Balance Sheet
Inhibitor Therapeutics, Inc. (INTI)
Inhibitor Therapeutics, Inc. (INTI)
source: myfinsight.com